- Home
- BIVI vs BHAT Comparison
BIVI vs BHAT Comparison
Compare BIVI & BHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- BHAT
- Stock Information
- Founded
- BIVI 2013
- BHAT 2010
- Country
- BIVI United States
- BHAT China
- Employees
- BIVI N/A
- BHAT N/A
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- BHAT Recreational Games/Products/Toys
- Sector
- BIVI Health Care
- BHAT Consumer Discretionary
- Exchange
- BIVI Nasdaq
- BHAT Nasdaq
- Market Cap
- BIVI 14.2M
- BHAT 12.3M
- IPO Year
- BIVI N/A
- BHAT 2019
- Fundamental
- Price
- BIVI $1.91
- BHAT $1.63
- Analyst Decision
- BIVI
- BHAT
- Analyst Count
- BIVI 0
- BHAT 0
- Target Price
- BIVI N/A
- BHAT N/A
- AVG Volume (30 Days)
- BIVI 184.5K
- BHAT 313.3K
- Earning Date
- BIVI 11-12-2025
- BHAT 04-30-2025
- Dividend Yield
- BIVI N/A
- BHAT N/A
- EPS Growth
- BIVI N/A
- BHAT N/A
- EPS
- BIVI N/A
- BHAT N/A
- Revenue
- BIVI N/A
- BHAT $18,724,190.00
- Revenue This Year
- BIVI N/A
- BHAT N/A
- Revenue Next Year
- BIVI N/A
- BHAT N/A
- P/E Ratio
- BIVI N/A
- BHAT N/A
- Revenue Growth
- BIVI N/A
- BHAT N/A
- 52 Week Low
- BIVI $1.42
- BHAT $1.51
- 52 Week High
- BIVI $75.00
- BHAT $35.00
- Technical
- Relative Strength Index (RSI)
- BIVI 46.41
- BHAT 39.52
- Support Level
- BIVI $1.81
- BHAT $1.66
- Resistance Level
- BIVI $2.07
- BHAT $1.85
- Average True Range (ATR)
- BIVI 0.13
- BHAT 0.12
- MACD
- BIVI 0.03
- BHAT -0.03
- Stochastic Oscillator
- BIVI 37.99
- BHAT 6.67
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.